Effective dose (radiation)
||This article may be too technical for most readers to understand. (May 2012)|
|Organs||Tissue weighting factors|
|Red Bone Marrow||0.12||0.12||0.12|
|Remainder of body||0.30||0.05||0.12|
The effective dose in radiation protection and radiology is a measure of the cancer risk to a whole organism due to ionizing radiation delivered non-uniformly to part(s) of its body. It takes into account both the type of radiation and the nature of each organ being irradiated.
The effective dose replaces the former effective dose equivalent, and is sometimes incorrectly called the dose equivalent, but should not be confused with the equivalent dose. "Equivalent dose" does not consider the type and amount of tissue exposed, so an equivalent dose applied to only a portion of the body will carry lower risk than if the same equivalent dose was applied to the whole body. An effective dose will carry the same effective risk to the whole organism regardless of where it was applied, and it will carry the same effective risk as the same amount of "equivalent dose" applied uniformly to the whole body. These doses can be added together and hence assume a linear no threshold model of cancer risk.
The effective dose is a reasonable way to assess the health effects of beta and alpha radiation on the skin and eyes, or the effects of radiotherapy applied selectively to a part of the body.
Effective doses are important in the calculation of committed dose due to internal exposures. Because background radiation has inhalation and ingestion components committed dose is required to calculate the dose from background radiation.
One sievert (100 rem) of effective dose carries with it a 4% chance of developing a fatal cancer in an average adult, and a 0.8% chance of hereditary defect in future offspring. This average is used in radiation protection although the risk to a given exposed individual depends on many factors, particularly age as cancers may develop years or decades after exposure. There is also an increased risk of survivable cancers, including some that will never be diagnosed.
A uniform field of penetrating radiation deposits the same amount of energy per unit mass in any organic material it hits. This is the absorbed dose, a quantity that is independent of body weight, organ size or tissue mass. To obtain an effective dose, the absorbed dose is first corrected for the radiation type to give the equivalent dose, and then corrected for the tissue receiving the radiation. Some tissues like bone marrow are particularly sensitive to radiation, so they are given a weighting factor that is disproportionally large relative to the fraction of body mass they represent. Other tissues like the hard bone surface are particularly insensitive to radiation and are assigned a disproportionally low weighting factor.
The sum of effective doses to each region of the body add up to the whole-body effective dose for the organism. If only part of the body is radiated, then only the regions radiated are used to add up an effective dose which can be compared to organisms that receive an equivalent dose uniformly over its whole body. Effective doses can be calculated and given out for specific procedures, such as a head CT scan.
More precisely, the effective dose of radiation (E) is found by calculating a weighted average of the equivalent dose (HT) in different body tissues, with the weighting factors (WT) designed to reflect the different importance of tissue types to the danger to the whole organism. Where the dose is only applied to a portion of a tissue or organ, it needs to be averaged across the entire mass of the tissue or organ in order to be representative of that tissue type.
- is the effective dose to the entire organism
- is the equivalent dose absorbed by tissue T
- is the tissue weighting factor defined by regulation
- is the radiation weighting factor defined by regulation
- is the mass-averaged absorbed dose in tissue T by radiation type R
- is the absorbed dose from radiation type R as a function of location
- is the density as a function of location
- is volume
- is the tissue or organ of interest
The tissue weighting factors (not to be confused with relative biological effectiveness factors used to calculate equivalent dose) are designed to estimate the fraction of health risk, or biological effect, which is attributable to the specific tissue named. These weighting factors have been revised twice, as shown in the chart above. The tissue weighting factors always add up to 1.0, so that if an entire organism is radiated with uniformly penetrating external radiation, the effective dose for the entire organism is equal to the equivalent dose for the entire organism.
Related Quantities 
Effective Dose Equivalent 
The US Nuclear Regulatory Commission has encoded into regulation the older term effective dose equivalent to refer to effective dose. The NRC's total effective dose equivalent (TEDE) is a sum of effective or equivalent doses with committed dose.
Cumulative equivalent 
Cumulative equivalent dose due to external whole-body exposure is normally reported to nuclear energy workers in regular dosimetry reports. In the US, three different effective doses are typically reported:
- deep-dose equivalent, (DDE) which is properly a whole-body equivalent dose
- shallow dose equivalent, (SDE) which is actually the effective dose to the skin
- eye dose equivalent (not defined in the NRC glossary)
Increased Cancer Risk 
In some situations the effective dose gives the best estimate of the excess relative risk of cancer. The Biologic Effects of Ionizing Radiation (BEIR) reports contain the relationship between dose and cancer calculated largely from dose reconstructions for A-bomb survivors.
The concept of effective dose was introduced in 1975. It was then included in 1977 as “effective dose equivalent” into Publication 26 by the International Commission on Radiological Protection, an international body that provides guidance on the risk caused by radiation. In 1990, ICRP publication 60 shortened the name to "effective dose." This quantity is sometimes incorrectly referred to as the "dose equivalent" because of the earlier name, and that misnomer in turn causes confusion with equivalent dose. The tissue weighting factors were revised in 1990 and 2007 because of new data.
- UNSCEAR-2008 Annex A page 40, table A1, retrieved 2011-7-20
- "1990 Recommendations of the International Commission on Radiological Protection". Annals of the ICRP. ICRP publication 60 21 (1-3). 1991. ISBN 978-0-08-041144-6. Retrieved 17 May 2012.
- "The 2007 Recommendations of the International Commission on Radiological Protection". Annals of the ICRP. ICRP publication 103 37 (2-4). 2007. ISBN 978-0-7020-3048-2. Retrieved 17 May 2012.
- Wrixon, A D (2007). "New ICRP recommendations". Journal of Radiation Protection 28: 161–168. doi:10.1088/0952-4746/28/2/R02.
- "Glossary". Tutorial on the Regulatory Control of Nuclear Power Plants. International Atomic Energy Agency. Retrieved 8 May 2012.
- 10 CFR 20.1003. US Nuclear Regulatory Commission. 2009. Retrieved 25 November 2012.
- Jodie A. Christner et al. Estimating Effective Dose for CT Using Dose–Length Product Compared With Using Organ Doses: Consequences of Adopting International Commission on Radiological Protection Publication 103 or Dual-Energy Scanning. 10.2214/AJR.09.3462 American Journal of Radiology (AJR) April 2010 vol. 194 no. 4 881-889.
- "Report in Brief Beir VII: Health Risks from Exposure to Low Levels of Ionizing Radiation". Earth and Life Studies at the National Academies. The National Academies. Retrieved 25 August 2012.
- Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII – Phase 2. National Academies Press. 2006. p. 248. ISBN 0-309-53040-7.
- Jacobi W (1975). "The concept of effective dose - A proposal for the combination of organ doses". Radiat. Environ. Biophys (12): 101–109.
See also 
- Collective dose
- Total effective dose equivalent
- Deep-dose equivalent
- Cumulative dose
- Committed dose equivalent
- Committed effective dose equivalent